GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » The Chemours Co (NYSE:CC) » Definitions » Debt-to-Equity

The Chemours Co (The Chemours Co) Debt-to-Equity

: 5.83 (As of Dec. 2023)
View and export this data going back to 2015. Start your Free Trial

The Chemours Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $106 Mil. The Chemours Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $4,193 Mil. The Chemours Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $737 Mil. The Chemours Co's debt to equity for the quarter that ended in Dec. 2023 was 5.83.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for The Chemours Co's Debt-to-Equity or its related term are showing as below:

CC' s Debt-to-Equity Range Over the Past 10 Years
Min: 3.51   Med: 5.26   Max: 35.44
Current: 5.83

During the past 13 years, the highest Debt-to-Equity Ratio of The Chemours Co was 35.44. The lowest was 3.51. And the median was 5.26.

CC's Debt-to-Equity is ranked worse than
99.21% of 1393 companies
in the Chemicals industry
Industry Median: 0.35 vs CC: 5.83

The Chemours Co Debt-to-Equity Historical Data

The historical data trend for The Chemours Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Chemours Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.49 5.26 3.69 3.51 5.83

The Chemours Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.51 3.15 4.80 5.60 5.83

Competitive Comparison

For the Specialty Chemicals subindustry, The Chemours Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Chemours Co Debt-to-Equity Distribution

For the Chemicals industry and Basic Materials sector, The Chemours Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where The Chemours Co's Debt-to-Equity falls into.



The Chemours Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

The Chemours Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

The Chemours Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Chemours Co  (NYSE:CC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


The Chemours Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of The Chemours Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


The Chemours Co (The Chemours Co) Business Description

Traded in Other Exchanges
Address
1007 Market Street, Wilmington, DE, USA, 19801
The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, it derives a majority of its revenue from North America.
Executives
Ron Christopher Charles officer: Senior Vice President, People C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sandra Phillips Rogers director 1000 CRANBERRY WOODS DRIVE, CRANBERRY TOWNSHIP PA 16066
Erin N Kane director 300 KIMBALL DRIVE, SUITE 101, PARSIPPANY NJ 07054
Joseph T. Martinko officer: President, Thermal & Specializ C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Mark Newman officer: Senior Vice President and CFO 1011 WARRENVILLE ROAD, SUITE 600, LISLE IL 60532
Alvenia Scarborough officer: SVP Corp Communications & CBO C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Matthew S Abbott officer: SVP, Chief Enterprise Transfor C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Guillaume Pepy director C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sean D Keohane director C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Calderon Gerardo Familiar officer: Pres Advanced Performance Mat C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Alisha Bellezza officer: President, Thermal Spec Solns C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Camela Wisel officer: VP, CAO & Controller C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sameer Ralhan officer: SVP, CFO C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19899
Jonathan Lock officer: SVP, Chief Development Officer C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Susan M. Kelliher officer: SVP, People and Health Service ALBEMARLE CORPORATION, 451 FLORIDA STREET, BATON ROUGE LA 70801